Fig. 12From: Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinomaA, BÂ ROC of the 4-gene signature (Zheng) risk model and LIHC KM curves of the High/Low group samples; C, D ROC of the 6-gene signature (Ke) risk model and LIHC KM curves of the High/Low group samples; E, F ROC of the 6-gene signature (Liu) risk model and LIHC KM curves of the High/Low group samples; G C-index for the 4 prognostic risk modelsBack to article page